Add-Aspirin trial: A phase III, double blind, placebo-controlled, randomized trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common nonmetastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results